A clinical trial to study the effects of a poly-herbal compound on immune status of healthy human subjects
Phase 2
Completed
- Registration Number
- CTRI/2022/05/042366
- Lead Sponsor
- Ms Saatvik Enterprises
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1-Apparently Healthy individuals aged 20-40 years of either sex.
2-Individuals giving consent for participation.
Exclusion Criteria
1-Individuals with chronic co-morbid conditions which might have affected the immune status of the individual.
2-Pregnant or lactating mother
3-Person on any interventional drug like vitamin/mineral/hormonal supplements/protein supplements etc. or any other nutritional supplements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Immune status as evaluated by ISQTimepoint: Baseline <br/ ><br>3 months from Baseline
- Secondary Outcome Measures
Name Time Method Changes in Immunoglobulin (IgG, IgM) levelsTimepoint: Baseline <br/ ><br>3 months from Baseline <br/ ><br>